NOT KNOWN FACTUAL STATEMENTS ABOUT PHARMA EXCIPIENTS

“The existing situation has exposed some structural weaknesses during the EU’s medicines offer chain in addition to a large dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides reported. She recommended that supply chain challenges be tackled in an EU pharmaceutical technique expected for being released by the end w